Cochoco, Jacob .
HRN: 26-41-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2024
CEFUROXIME 750MG (VIAL)
12/21/2024
12/28/2024
IV
630mg
Q8h
Dengue Fever With WS
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes